More than 20 companies and research institutes have brought their candidates into human testing at record speed. The United State government’s Operation Warp Speed -- an effort to bring a vaccine to market by January -- is paying out billions of dollars to promising candidates. Moderna, Inovio Pharmaceuticals and Novavax are frontrunners in the race, with investors betting heavily that they will be among the first.
News 
Market Data 
Discover 
